Evaluation of prophylactic dosages of Enoxaparin in non-surgical elderly patients with renal impairment

BACKGROUND: Thromboprophylaxis dosing strategies using enoxaparin in elderly patients with renal disease are limited, while dose adjustments or monitoring of anti-Xa levels are recommended. We sought to evaluate the efficacy and safety of enoxaparin 20 mg versus 30 mg subcutaneously daily by compari...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:BMC Pharmacol Toxicol
Autori principali: Chamoun, Nibal, Ghanem, Hady, Hachem, Ahmad, Hariri, Essa, Lteif, Christelle, Mansour, Hanine, Dimassi, Hani, Zalloum, Richard, Ghanem, Georges
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2019
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6505244/
https://ncbi.nlm.nih.gov/pubmed/31064405
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40360-019-0308-8
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi